Seguir
Valéria de Almeida
Valéria de Almeida
Pós-doutoranda - Instituto de Biologia, Unicamp
E-mail confirmado em g.unicamp.br
Título
Citado por
Citado por
Ano
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
V Almeida, R Levin, FF Peres, ST Niigaki, MB Calzavara, AW Zuardi, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 41, 30-35, 2013
1092013
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
R Levin, FF Peres, V Almeida, MB Calzavara, AW Zuardi, JEC Hallak, ...
Frontiers in pharmacology 5, 10, 2014
762014
Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
FF Peres, R Levin, MA Suiama, MC Diana, DA Gouvêa, V Almeida, ...
Frontiers in pharmacology 7, 343, 2016
752016
Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats
MB Calzavara, R Levin, WA Medrano, V Almeida, APF Sampaio, ...
Behavioural brain research 225 (1), 15-22, 2011
652011
Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
FF Peres, MC Diana, R Levin, MA Suiama, V Almeida, AM Vendramini, ...
Frontiers in pharmacology 9, 2018
562018
Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain
V Almeida, FF Peres, R Levin, MA Suiama, MB Calzavara, AW Zuardi, ...
Schizophrenia research 153 (1-3), 150-159, 2014
562014
Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia
R Levin, V Almeida, F Fiel Peres, M Bendlin Calzavara, N Derci da Silva, ...
Current pharmaceutical design 18 (32), 4960-4965, 2012
552012
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
FF Peres, MC Diana, MA Suiama, V Justi, V Almeida, RA Bressan, ...
Schizophrenia research 172 (1), 220-221, 2016
342016
Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
FF Peres, R Levin, V Almeida, AW Zuardi, JE Hallak, JA Crippa, VC Abilio
Frontiers in Pharmacology 7, 196956, 2016
272016
Cannabinoids and glial cells: possible mechanism to understand schizophrenia
V de Almeida, D Martins-de-Souza
European archives of psychiatry and clinical neuroscience 268, 727-737, 2018
222018
Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients
V de Almeida, GL Alexandrino, A Aquino, AF Gomes, M Murgu, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, 109945, 2020
212020
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
V Almeida, R Levin, FF Peres, MA Suiama, AM Vendramini, CM Santos, ...
Neuropharmacology, 2019
212019
Biochemical pathways triggered by antipsychotics in human oligodendrocytes: Potential of discovering new treatment targets
C Brandão-Teles, VR De Almeida, JS Cassoli, D Martins-de-Souza
Frontiers in pharmacology 10, 351461, 2019
202019
Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities
ST Niigaki, FF Peres, L Ferreira, T Libanio, DA Gouvea, R Levin, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2018
202018
Ubiquitin–proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia
G Seabra, V de Almeida, G Reis-de-Oliveira, F Crunfli, ASLM Antunes, ...
Scientific reports 10 (1), 12655, 2020
162020
Digging deeper in the proteome of different regions from schizophrenia brains
G Reis-de-Oliveira, GS Zuccoli, M Fioramonte, A Schimitt, P Falkai, ...
Journal of proteomics 223, 103814, 2020
152020
Proteomic markers for depression
LC Silva-Costa, PT Carlson, PC Guest, V de Almeida, ...
Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders …, 2019
122019
Proteomics and lipidomics in the elucidation of endocannabinoid signaling in healthy and schizophrenia brains
G Seabra, ACB Falvella, PC Guest, D Martins‐de‐Souza, V de Almeida
Proteomics 18 (18), 1700270, 2018
92018
The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research
L Krčmář, I Jäger, E Boudriot, K Hanken, V Gabriel, J Melcher, N Klimas, ...
Frontiers in Psychiatry 14, 1179811, 2023
72023
Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Front Pharmacol 2018; 9: 901
FF Peres, MC Diana, R Levin, MA Suiama, V Almeida, AM Vendramini
72018
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20